SCHEMBL24413627

SCHEMBL24413627

CCOc1ccc(C(C)C)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
HSD17B10 Q99714 1/20 0.53
KMT2A Q03164 3/20 0.48
LMNA P02545 1/20 0.48
BCHE P06276 2/20 0.46
ACHE P22303 2/20 0.46
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.42
PTGS2 P35354 2/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRB3 P13945 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26723828 0.88 PTPN11 (0.49) HSD17B10KMT2ABCHEACHEHSP90AA1
SCHEMBL9945944 0.87 TSHR (0.57) TSHRKMT2ALMNABCHEACHE
SCHEMBL4601249 0.84 RXRA (0.56) TSHRHSD17B10KMT2ALMNAADRB1
SCHEMBL26204598 0.84 PTPN11 (0.46) KMT2ABCHEACHEHSP90AA1HSP90AB1
SCHEMBL28213139 0.83 ALOX15 (0.48) HSD17B10KMT2ABCHEACHEHSP90AA1
SCHEMBL382849 0.82 FOLH1 (0.62) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL1640086 0.82 GAA (0.63) TSHRBCHEACHEALDH1A1KDM4E
SCHEMBL487560 0.81 ALDH1A1 (0.50) HSD17B10KMT2AACHEALDH1A1KDM4E
SCHEMBL8471711 0.80 KMT2A (0.60) TSHRHSD17B10KMT2ALMNAALDH1A1
SCHEMBL4317654 0.80 ALDH1A1 (0.50) HSD17B10KMT2ALMNAHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 US disclosed
US-20220143183-A1 PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF NEW YORK UNIVERSITY 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11873291-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS TSHR 2355/4885HSD17B10 2690/4885KMT2A 4371/4885
US-20220143183-A1 PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF MDM2, UBE3C, CUL1 TSHR 2647/4885HSD17B10 4138/4885KMT2A 777/4885
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS TSHR 2355/4885HSD17B10 2690/4885KMT2A 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.